Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 2

Immune Cells in the Tumor Microenvironment I

Saturday, April 18, 2026
9:45 AM - 11:15 AM US ET
Location: 156

    Moderator(s)

  • MP

    Mary Philip

    Vanderbilt University Medical Center

  • AB

    Arya Biragyn, PhD

    Senior Investigator, Chief
    Immunoregulation section
    National Institute on Aging, National Institutes of Health
    Baltimore, Maryland, United States

Presentations:

  • 9:45 AM - 10:00 AM US ET
    T cell adaption to bile acids is critical for their responses during liver tumors.

    Author: Siva Karthik Varanasi – UMass Chan Med. Sch.

  • 10:00 AM - 10:15 AM US ET
    GSDME-Mediated Pyroptosis Suppresses Anti-Tumor Immunity via IL-1α–Dependent Recruitment of Immunosuppressive Myeloid Cells

    Author: Yu Mei – Natl. Univ. of Singapore

  • 10:15 AM - 10:30 AM US ET
    Targeting Pros1 to improve chemotherapy efficacy and immune anti-tumor response

    Author: Nestor Prieto-Dominguez, PhD (he/him/his) – University of Kentucky

  • 10:30 AM - 10:45 AM US ET
    Exocyst complex regulates fungal-mediated IL-33 release and facilitates type 2 immune response

    Author: Aftab Alam, PhD (he/him/his) – Roswell Park Comprehensive Cancer Center